Mild
[대역어] 약한
[용어속성] Term
[용어속성] Term
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial
Article
[키워드] acute respiratory syndrome
Administered
Adults
adverse event
AEs
age
analysis
assessment
assigned
BNT162b2
BNT162b2 mRNA
BNT162b2 mRNA vaccine
China
Chinese
clinical trial
Complete
Completed
conducted
coronavirus
COVID-19
development
dose
double-blind
Efficacy and safety
enrolled
Follow-up
geometric mean titer
GMT
GMTs
Han Chinese
healthy
immune response
immunogenicity
immunogenicity endpoint
Inc
independent
individual
injection
intramuscular
Intramuscular injection
investigators
Laboratory parameters
management
messenger
Messenger RNA
Mild
moderate
mRNA vaccine
Neutralising Antibodies
neutralising antibody
of BNT162b2
participant
Participants
pharmaceutical
Placebo
placebo-controlled trial
randomisation
randomised
Randomly
reactogenicity
receive
recipients
recruited
reduced
remained
reported
resolved
Result
robust
Safety
SARS-CoV-2
SARS-CoV-2 variant
SCR
second dose
sera
serious AE
seroconversion rate
severity
Shanghai
Sponsor
statisticians
stratified
T-cell Response
the placebo group
Tolerability
Treatment
Trial
utilised
vaccination
vaccination.
vaccine administration
were blinded
[DOI] 10.1016/j.lanwpc.2022.100586 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.lanwpc.2022.100586 PMC 바로가기 [Article Type] Article
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients
Article
[키워드] addition
affecting
alleviate
antiviral medication
antiviral medicine
approved
Baricitinib
Care
caused
Clinical practice
clinical recommendations
Community
courses
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19 treatment
COVID-19 treatments
Critical
deaths
develop
disease
disorder
drug
Dyspnea
effective
effective drugs
European
European Medicines Agency
European Union
Evidence
guidelines.
Health
healthcare
hospital
Hospitalization
Hospitalized
hospitalized patient
hypoxia
Intervention
involved
life-threatening
lung involvement
management
Mild
moderate
molnupiravir
monoclonal antibodies
monoclonal antibody
Most patient
Multiorgan dysfunction
New
outcome
public health
recommendation
Remdesivir
Respiratory failure
rheumatoid arthritis
SARS-CoV-2
Septic shock
severe symptom
Symptom
the disease
the patient
therapy
Thromboembolism
Tocilizumab
treat
Treatment
treatment strategy
union
vaccination
[DOI] 10.1080/07853890.2022.2133162 PMC 바로가기
[DOI] 10.1080/07853890.2022.2133162 PMC 바로가기
Association of iron-related biomarkers with severity and mortality in COVID-19 patients
Article
Published on
Journal: Journal of trace elements in medicine and biology
[Category] COVID19(2023년), SARS, 바이오마커, 치료기술,
Journal: Journal of trace elements in medicine and biology
[Category] COVID19(2023년), SARS, 바이오마커, 치료기술,
[키워드] Activation
Analysis
analyzed
association
AUC
biological processes
Biomarker
can be used
characterized
Combination
continuous monitoring
contribute
Control
controls
Course
COVID
COVID 19
COVID-19
COVID-19 patient
cutoff point
Deceased
decrease
deficiency
demonstrated
discharged
ferritin
healthy individual
highest
IL-6
immune responses
immune system
immunomodulatory
individual
infected with COVID-19
Infection
Inflammation
iron
marker
material
Mild
moderate
Mortality
multiple regression model
outcome
oxidative stress
parameter
patients with COVID-19
receiver operating characteristic
recruited
regulate
required
ROC
ROC Curve
SARS-CoV-2 patients
sensitivity
serum
severe disease
severity
shown
significant difference
significantly
significantly increased
specificity
stepwise AIC selection
survival
susceptibility
the cytokine storm
the median
trace
Trace element
Trace metals
Transferrin
Transferrin.
variable
variety
viral infections
[DOI] 10.1016/j.jtemb.2022.127075 PMC 바로가기
[DOI] 10.1016/j.jtemb.2022.127075 PMC 바로가기
Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort
Article
[키워드] acute respiratory syndrome
adverse event
adverse events
Breakthrough infection
China
clinical manifestation
Cohort
collected
concerning
conducted
coronavirus
Coronavirus disease 2019
COVID-19
COVID-19 vaccination
decrease
Efficacy
enrolled
fatigue
feature
grade 3
higher risk
inactivated
Inactivated vaccine
Infection
infections
liver
liver dysfunction
Liver transplantation
Mild
myalgia
occurred
omicron
participant
Patient
patients
postoperative
protection rate.
recipient
retrospective cohort
Retrospective study
Safe
safety profile
SARS-CoV-2
Seven
vaccination
Vaccine
variant
viral shedding
were infected
whole-virion SARS-CoV-2 vaccine
[DOI] 10.1080/22221751.2022.2136535 PMC 바로가기
[DOI] 10.1080/22221751.2022.2136535 PMC 바로가기
Sudden unexpected death in a 17-year-old boy due to unacknowledged adamantinoma-like Ewing sarcoma
Article
Published on
Journal: Forensic Science, Medicine, and Pathology
[Category] COVID19(2023년), SARS, 바이오마커, 진단, 치료기술,
Journal: Forensic Science, Medicine, and Pathology
[Category] COVID19(2023년), SARS, 바이오마커, 진단, 치료기술,
[키워드] Abnormalities
Adamantinoma-like Ewing sarcoma
addition
airway
Airway occlusion
Analysis
analysis
anatomical
Autopsy
Blood
Brain
break
cardiac
cause
CD99
Cell
characterized
Chest radiography
Complete
death
diagnosed
diagnostic
diagnostics
died
discharged
disease
Dyspnea
EWSR1
excluded
expression
Forensic
Forensic autopsy
forensic pathology
Germany
histopathological
hospital
immunohistochemistry
Invasion
Leica
Local
lung
macroscopic
male
mechanism
Microscopy
Mild
molecular
Nasopharyngeal swab
neoplasm
nucleoli
organ
oxygen saturation
pathology
probe
SARS-CoV-2
Soft tissue
subject
sudden
Sudden unexpected death.
tested
Thyroid
was performed
[DOI] 10.1007/s12024-022-00525-x PMC 바로가기
[DOI] 10.1007/s12024-022-00525-x PMC 바로가기
The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil
Research article
[키워드] Brazil
Clinical characteristics
collected
Community
conducted
cough
COVID-19
COVID-19 patients
COVID-19 research
develop
diabetes
died
disease
disease severity
epidemiological
Evolution
Follow-up
headache
Health
Hospitalized
hypertension
implementation
IQR
management
median age
men
Mild
moderate disease
MONITOR
myalgia
objective
participant
Patient
patients
Personal protective equipment
positive
progression
prospective observational cohort
public health
public health surveillance
Research
Result
SARS-CoV-2
SARS-CoV-2 genome
SARS-CoV-2 positivity
SARS-CoV-2 RNA
Seven
severe disease
state
study period
Support
Surveillance
Swab
Symptom
the epidemic
variants
was increased
were assessed
women
World Health Organization
[DOI] 10.1016/j.puhip.2022.100301 [Article Type] Research article
[DOI] 10.1016/j.puhip.2022.100301 [Article Type] Research article
Development of a magnetic nanoparticle-based method for concentrating SARS-CoV-2 in wastewater
Article
[키워드] acute respiratory syndrome
affected
applicability
applied
comparable
Concentration
coronavirus
detect
Detection sensitivity
development
Epidemiology
limitations
log
magnetic nanoparticle
Mild
MNP
Modification
MS2
Pegcision
Polyethylene glycol
Polyethylene glycol precipitation
polymerase chain
Pseudomona
quantified
reducing
SARS-CoV-2
SARS-CoV-2 RNA
sensitivity
virus
virus
virus concentration
viruses
Wastewater-based epidemiology.
[DOI] 10.1016/j.scitotenv.2022.157613 PMC 바로가기
[DOI] 10.1016/j.scitotenv.2022.157613 PMC 바로가기
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients
Article
[키워드] 95% CI
95% confidence interval
adjusted odds ratio
Administered
age
Characteristics
clinical trial
Comorbidity
COVID-19
COVID-19 outpatient
death
defined
died
early symptomatic COVID-19
effective
Electronic health record
health system
Hospitalization
Hospitalized
immunocompromised status
lack
mAb
mAbs
Male sex
Mild
monoclonal antibodies
monoclonal antibody
monoclonal antibody treatment
Mortality
mortality data
multicenter
Neutralizing
obesity
Observational cohort study
occurred
pandemic
Patient
patients
patients with COVID-19
positive
Primary outcome
real-world data
reducing
SARS-CoV-2
SARS-CoV-2 test
SARS-CoV-2 vaccination
SARS-CoV-2.
Treatment
Vaccine
variants
while
[DOI] 10.1186/s12879-022-07819-z PMC 바로가기
[DOI] 10.1186/s12879-022-07819-z PMC 바로가기
Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death
Article
[키워드] acid
Alter
alteration
Biomarker
caused
cell death
change
circulating
Cohort
contribute
COVID-19
COVID-19 patient
disease
dysfunction
Europe
exclusion
FABP2
functional
Gut
immune
include
increase in
Infection
Inflammation
Inflammatory responses
inhibited
marker
median
metabolites
microbial product
Mild
moderate
NMR
outliers
pathology
Patient
patients with moderate
plasma
Plasma marker
positive correlation
reduced
reduction in
route of infection
SARS-CoV-2
SARS-COV-2 infection
severe COVID-19
severe disease
severe group
Severity of disease
shown
systemic
[DOI] 10.1038/s41598-022-23282-x PMC 바로가기
[DOI] 10.1038/s41598-022-23282-x PMC 바로가기